XNK Therapeutics Alternatives & Competitors
12 companies similar to XNK Therapeutics — INDIVIDUALIZED NK CELL THERAPIES
Companies similar to XNK Therapeutics
Alaunos Therapeutics
Attacking solid tumors with TCRs
Houston, United States
Jounce Therapeutics, Inc.
Daring to create a world immune to cancer.
Cambridge, United States
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Australia
TScan Therapeutics
Unleash Immunity
Waltham, United States
Rival Readout
Competing with XNK Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Kiromic Biopharma, Inc.
Cell therapy company with end-to-end bioinformatic, AI targeting, and manufacturing techno...
Houston, United States
Imvax, Inc.
Imvax is a clinical-stage biotechnology company developing personalized, whole tumor-deriv...
Philadelphia, United Stat...
Jasper Therapeutics
Jasper is a biotechnology company focused on targeting mast cells and stem cells to treat...
Redwood City, United Stat...
Pacylex Pharmaceuticals, Inc.
A new target in cancer care - triggering selective lethality with a new class of drugs.
Edmonton, Canada
PNP Therapeutics, Inc.
Clinical-stage biopharmaceuticals developing cancer treatment platform with proprietary pr...
Lisata Therapeutics, Inc.
Targeted Therapy Delivered
United States
Simcha Therapeutics
Overcoming biological challenges in clinically translatable pathways.
New Haven, United States
ADC Therapeutics
Innovating Science. Inspiring Hope.
Lausanne, Switzerland
About XNK Therapeutics
XNK Therapeutics is a clinical-stage biotechnology company with a mission to develop individualized and unique natural killer (NK) cell-based cancer therapies. Their R&D pipeline focuses on addressing unmet medical needs in hematological malignancies and solid tumors. Their most advanced product candidate, evencaleucel...
NK Cell Therapy, Cancer Treatment, Clinical-stage, Hematological Malignancies, Solid Tumors, Evencaleucel, Isatuximab, Stem Cell Transplantation, Multiple Myeloma, Proprietary Technology Platform, GMP Facility, Karolinska Institute, Autologous Therapy, Clinical Study
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around XNK Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at XNK Therapeutics on 12 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 10 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
